• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Dec;28(13):S26-S33.
doi: 10.3201/eid2813.212248.
Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic

Perrine Marcenac, Margaret McCarron, William Davis, Ledor S Igboh, Joshua A Mott, Kathryn E Lafond, Weigong Zhou, Marjorie Sorrells, Myrna D Charles, Philip Gould, Carmen Sofia Arriola, Vic Veguilla, Erica Guthrie, Vivien G Dugan, Rebecca Kondor, Eric Gogstad, Timothy M Uyeki, Sonja J Olsen, Gideon O Emukule, Siddhartha Saha, Carolyn Greene, Joseph S Bresee, John Barnes, David E Wentworth, Alicia M Fry, Daniel B Jernigan, Eduardo Azziz-Baumgartner
Free article

Abstract

A network of global respiratory disease surveillance systems and partnerships has been built over decades as a direct response to the persistent threat of seasonal, zoonotic, and pandemic influenza. These efforts have been spearheaded by the World Health Organization, country ministries of health, the US Centers for Disease Control and Prevention, nongovernmental organizations, academic groups, and others. During the COVID-19 pandemic, the US Centers for Disease Control and Prevention worked closely with ministries of health in partner countries and the World Health Organization to leverage influenza surveillance systems and programs to respond to SARS-CoV-2 transmission. Countries used existing surveillance systems for severe acute respiratory infection and influenza-like illness, respiratory virus laboratory resources, pandemic influenza preparedness plans, and ongoing population-based influenza studies to track, study, and respond to SARS-CoV-2 infections. The incorporation of COVID-19 surveillance into existing influenza sentinel surveillance systems can support continued global surveillance for respiratory viruses with pandemic potential.

Keywords: COVID-19; SARS-CoV-2; coronavirus disease; epidemiologic surveillance; influenza; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine deployment; vaccine-preventable diseases; viruses; zoonoses.
 
Back
Top Bottom